[go: up one dir, main page]

AU2001290524A1 - Soluble zcytor 11 cytokine receptors - Google Patents

Soluble zcytor 11 cytokine receptors

Info

Publication number
AU2001290524A1
AU2001290524A1 AU2001290524A AU9052401A AU2001290524A1 AU 2001290524 A1 AU2001290524 A1 AU 2001290524A1 AU 2001290524 A AU2001290524 A AU 2001290524A AU 9052401 A AU9052401 A AU 9052401A AU 2001290524 A1 AU2001290524 A1 AU 2001290524A1
Authority
AU
Australia
Prior art keywords
cytokine receptors
receptor
antagonist
seq
soluble zcytor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290524A
Other languages
English (en)
Inventor
Wayne R. Kindsvogel
Stavros Topouzis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of AU2001290524A1 publication Critical patent/AU2001290524A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Steroid Compounds (AREA)
AU2001290524A 2000-08-08 2001-08-08 Soluble zcytor 11 cytokine receptors Abandoned AU2001290524A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22382700P 2000-08-08 2000-08-08
US60/223,827 2000-08-08
US25087600P 2000-12-01 2000-12-01
US60/250,876 2000-12-01
PCT/US2001/024838 WO2002012345A2 (fr) 2000-08-08 2001-08-08 Recepteurs de cytokines zcytor 11 solubles

Publications (1)

Publication Number Publication Date
AU2001290524A1 true AU2001290524A1 (en) 2002-02-18

Family

ID=26918167

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290524A Abandoned AU2001290524A1 (en) 2000-08-08 2001-08-08 Soluble zcytor 11 cytokine receptors

Country Status (9)

Country Link
US (5) US7045498B2 (fr)
EP (2) EP2177616B1 (fr)
JP (1) JP5015404B2 (fr)
AT (2) ATE342980T1 (fr)
AU (1) AU2001290524A1 (fr)
CA (1) CA2418950A1 (fr)
DE (1) DE60123998T2 (fr)
ES (1) ES2381650T3 (fr)
WO (1) WO2002012345A2 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965704A (en) * 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
WO2002012345A2 (fr) * 2000-08-08 2002-02-14 Zymogenetics, Inc. Recepteurs de cytokines zcytor 11 solubles
ES2267814T3 (es) 2000-09-15 2007-03-16 Zymogenetics, Inc. Metodo para tratar la inflamacion.
US7094570B2 (en) 2003-03-11 2006-08-22 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which encode a soluble IL-TIF/IL-22 receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
US7268223B2 (en) * 2000-09-22 2007-09-11 Wyeth Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
JP2004533811A (ja) 2001-01-12 2004-11-11 ジェネティクス インスティテュート，エルエルシー ２型サイトカインレセプターおよび２型サイトカインレセプターをコードする核酸
IL161978A0 (en) 2001-12-17 2005-11-20 Zymogenetics Inc Method for treating cervical cancer
CN1774445A (zh) * 2002-08-16 2006-05-17 惠氏公司 用于治疗rage相关病症的组合物和方法
CN1845937A (zh) * 2003-03-24 2006-10-11 津莫吉尼蒂克斯公司 抗il－20抗体和结合伴侣以及在炎症中的使用方法
MXPA05010134A (es) * 2003-03-24 2005-11-16 Zymogenetics Inc Anticuerpos anti-il-20, metodos y moleculas de enlace que se usan en la inflamacion.
JP4991307B2 (ja) 2003-11-21 2012-08-01 ザイモジェネティクス， インコーポレイテッド 抗ｉｌ−２０抗体および結合パートナーならびに炎症において用いる方法
US7537761B2 (en) * 2004-10-22 2009-05-26 Zymogenetics, Inc. Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
EP1827469A2 (fr) * 2004-11-22 2007-09-05 Henry J. Smith Recepteurs cellulaires utilises comme excipients pour composes pharmaceutiques servant dans le traitement de l'arthrite, et des troubles inflammatoires et immunitaires
CA2596390A1 (fr) 2005-02-08 2006-08-17 Zymogenetics, Inc. Anticorps et partenaires de liaison anti-il-20, anti-il-22 et anti-il-22ra, et methodes d'utilisation de ces anticorps et partenaires de liaison dans des processus inflammatoires
US20070054360A1 (en) 2005-05-12 2007-03-08 Zeren Gao Compositions and methods for modulating immune responses
US7180469B2 (en) * 2005-06-29 2007-02-20 Cushcraft Corporation System and method for providing antenna radiation pattern control
US7932055B2 (en) 2006-06-22 2011-04-26 Novo Nordisk A/S Soluble heterodimeric CD94/NKG2 receptors fusion proteins
ES2564634T3 (es) 2007-06-14 2016-03-28 Galactica Pharmaceuticals, Inc. Proteínas de fusión de RAGE
WO2010096394A2 (fr) 2009-02-17 2010-08-26 Redwood Biosciences, Inc. Véhicules de médicaments à base de protéine marqués par aldéhyde et procédés d'utilisation
WO2011104381A2 (fr) 2010-02-26 2011-09-01 Novo Nordisk A/S Compositions stables contenant des anticorps
CA2800188A1 (fr) 2010-05-28 2011-12-01 Novo Nordisk A/S Compositions stables multi-doses comprenant un anticorps et un agent conservateur
US9540438B2 (en) 2011-01-14 2017-01-10 Redwood Bioscience, Inc. Aldehyde-tagged immunoglobulin polypeptides and methods of use thereof
JP2019515677A (ja) 2016-04-26 2019-06-13 アール．ピー．シェーラー テクノロジーズ エルエルシー 抗体複合体ならびにそれを作製および使用する方法
KR20210025054A (ko) * 2018-06-21 2021-03-08 샤턱 랩스 인코포레이티드 이형이량체 단백질 및 이의 용도
WO2022032022A2 (fr) * 2020-08-05 2022-02-10 Synthekine, Inc. Molécules de liaison au récepteur il10 et leurs procédés d'utilisation
CN117425674A (zh) 2021-03-02 2024-01-19 丹娜法伯癌症研究院 治疗红细胞疾患的方法

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654090A (en) 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
WO1989004838A1 (fr) * 1987-11-25 1989-06-01 Immunex Corporation Recepteurs d'interleukine-1
US4847325A (en) 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5567584A (en) 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US5436155A (en) 1991-12-31 1995-07-25 Arch Development Corporation Isolated DNA encoding a somatostatin receptor
US5789192A (en) 1992-12-10 1998-08-04 Schering Corporation Mammalian receptors for interleukin-10 (IL-10)
DE69740038D1 (fr) * 1996-07-12 2010-12-16 Genentech Inc
US5843697A (en) * 1996-07-17 1998-12-01 University Of Medicine And Dentistry Of New Jersey Cells expressing IL-10 receptor and the CRFB4 gene product, an IL-10 receptor accessory protein
US5985614A (en) 1996-08-30 1999-11-16 Human Genome Sciences, Inc. Polynucleotides encoding interleukin-19
US5945511A (en) 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
US6486301B1 (en) 1997-07-16 2002-11-26 Human Genome Sciences, Inc. Interleukin-20
EP1012260A4 (fr) 1997-07-16 2001-05-09 Human Genome Sciences Inc Interleukine-20
US5965704A (en) * 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
US6020163A (en) 1997-08-06 2000-02-01 Zymogenetics, Inc. Lipocalin homolog
CN1618969A (zh) 1997-11-26 2005-05-25 津莫吉尼蒂克斯公司 哺乳动物细胞因子样多肽－10
US6576743B1 (en) 1997-11-26 2003-06-10 Zymogenetics, Inc. Mammalian cytokine-like polypeptide-10
PT1047781E (pt) 1998-01-23 2004-11-30 Immunex Corp Receptores de il-18
EP1062332A2 (fr) 1998-03-09 2000-12-27 Schering Corporation Proteines receptrices humaines; reactifs et procedes associes
DK1490386T3 (da) 1998-03-10 2008-12-15 Genentech Inc Nyt polypeptid og nukleinsyrer kodende for dette
US6982320B2 (en) 1998-03-19 2006-01-03 Human Genome Sciences, Inc. Cytokine receptor common gamma chain like
WO1999061630A2 (fr) 1998-05-26 1999-12-02 Regeneron Pharmaceuticals, Inc. Molecules chimeriques comprenant un domaine de liaison a ligand extracellulaire d'un recepteur et une fc a ige ou une region constante, et leur utilisation dans un systeme d'essai
ATE251181T1 (de) * 1998-07-28 2003-10-15 Micromet Ag Heterominikörper
NZ510464A (en) 1998-09-01 2004-05-28 Genentech Inc Further pro polypeptides and sequences thereof
US6472179B2 (en) * 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US6274710B1 (en) 1998-10-26 2001-08-14 Ludwig Institute For Cancer Research Antibodies which specifically bind T Cell inducible factors (TIFs)
US6331613B1 (en) 1998-10-26 2001-12-18 Ludwig Institue For Cancer Research Isolated nucleic acid molecules which encode T cell inducible factors (TIFS), the proteins encoded, and uses thereof
AU2222700A (en) 1998-12-31 2000-07-31 Millennium Pharmaceuticals, Inc. Class ii cytokine receptor-like proteins and nucleic acids encoding them
WO2000065027A2 (fr) 1999-04-28 2000-11-02 Genetics Institute, Inc. Proteines humaines gil-19/ae289 et polynucleotides les codant
CA2373231A1 (fr) 1999-05-19 2000-11-23 Incyte Genomics, Inc. Molecules de signalisation extracellulaires
WO2000073457A1 (fr) 1999-05-27 2000-12-07 Schering-Corporation Homologues mammaliens d'interleukine-10:il-d110 et il-d210
CA2372511C (fr) 1999-06-15 2011-11-22 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques les codant
AU2883700A (en) 1999-06-23 2001-01-09 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2378519C (fr) 1999-07-07 2011-01-25 Zymogenetics, Inc. Recepteur de cytokine humaine
EP1208202A2 (fr) * 1999-09-01 2002-05-29 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci
AU1919201A (en) 1999-11-18 2001-05-30 Schering Corporation Mammalian receptor proteins; related reagents and methods
US6897292B2 (en) * 1999-12-03 2005-05-24 Zymogenetics, Inc. Human cytokine receptor
CA2395539C (fr) 1999-12-23 2009-08-25 Zymogenetics, Inc. Recepteur soluble de l'interleukine-20
ATE459716T1 (de) 1999-12-23 2010-03-15 Zymogenetics Inc Zytokin zcyt018
ATE459369T1 (de) 1999-12-23 2010-03-15 Zymogenetics Inc Verfahren zur behandlung von entzündungen
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
NZ523122A (en) 2000-06-22 2004-06-25 Smithkline Beecham Corp Polypeptides and polynucleotides and methods of identifying agonists and antagonists in relation to treatment of diseases
WO2002012345A2 (fr) * 2000-08-08 2002-02-14 Zymogenetics, Inc. Recepteurs de cytokines zcytor 11 solubles
EP2298789B1 (fr) 2000-09-08 2012-03-14 Schering Corporation Gènes mammaliens, reactifs et méthodes associés
ES2267814T3 (es) 2000-09-15 2007-03-16 Zymogenetics, Inc. Metodo para tratar la inflamacion.
US7268223B2 (en) 2000-09-22 2007-09-11 Wyeth Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
US20030022827A1 (en) 2000-09-25 2003-01-30 Bertram Weiss Three new members of the cytokine receptor family class 2
JP2004533811A (ja) 2001-01-12 2004-11-11 ジェネティクス インスティテュート，エルエルシー ２型サイトカインレセプターおよび２型サイトカインレセプターをコードする核酸
EP1390060A2 (fr) 2001-01-26 2004-02-25 Eli Lilly And Company Utilisation de lp82 pour traiter les problemes de poids
NZ527396A (en) 2001-02-23 2007-12-21 Genetics Inst Llc Antibodies and fragments thereof for the binding of IL-22 and use therefore for treating inflammatory disorders
CA2433933A1 (fr) 2001-02-28 2002-09-12 Eli Lilly And Company Utilisation de lp82 pour traiter les troubles hematopoietiques
JP2004532624A (ja) 2001-03-02 2004-10-28 ザイモジェネティクス，インコーポレイティド マウスサイトカイン受容体
AU2002245652A1 (en) 2001-03-09 2002-09-24 Zymogenetics, Inc. Soluble heterodimeric cytokine receptor
US20040086908A1 (en) 2002-03-07 2004-05-06 Chandrasekher Yasmin A. Soluble heterodimeric cytokine receptor
WO2002077174A2 (fr) 2001-03-27 2002-10-03 Zymogenetics, Inc. Recepteur de cytokine humaine
EP1439850A4 (fr) 2001-10-22 2006-05-03 Lilly Co Eli Proteines solubles inhibant les voies de transduction du signal de la cytokine
DE10154579A1 (de) 2001-11-07 2003-05-28 Medigene Ag Topikale Verwendung von Cytokinen und Chemokinen zur Behandlung von viralen oder mykotischen Hauterkrankungen oder Tumorerkrankungen
IL161978A0 (en) 2001-12-17 2005-11-20 Zymogenetics Inc Method for treating cervical cancer
US20040236075A1 (en) 2002-07-24 2004-11-25 Laure Dumoutier Novel glass II cytokine receptors, and uses thereof
MXPA05010134A (es) 2003-03-24 2005-11-16 Zymogenetics Inc Anticuerpos anti-il-20, metodos y moleculas de enlace que se usan en la inflamacion.
JP4991307B2 (ja) 2003-11-21 2012-08-01 ザイモジェネティクス， インコーポレイテッド 抗ｉｌ−２０抗体および結合パートナーならびに炎症において用いる方法
US7537761B2 (en) 2004-10-22 2009-05-26 Zymogenetics, Inc. Anti-IL-22RA antibodies and binding partners and methods of using in inflammation

Also Published As

Publication number Publication date
CA2418950A1 (fr) 2002-02-14
EP1337636B1 (fr) 2006-10-18
EP2177616A1 (fr) 2010-04-21
US20060068471A1 (en) 2006-03-30
WO2002012345A2 (fr) 2002-02-14
US20110081344A1 (en) 2011-04-07
US7045498B2 (en) 2006-05-16
WO2002012345A3 (fr) 2003-06-12
US20100047168A1 (en) 2010-02-25
ES2381650T3 (es) 2012-05-30
US20030157096A1 (en) 2003-08-21
DE60123998D1 (de) 2006-11-30
US20130028894A1 (en) 2013-01-31
EP2177616B1 (fr) 2012-02-29
JP2004505641A (ja) 2004-02-26
JP5015404B2 (ja) 2012-08-29
DE60123998T2 (de) 2007-09-06
US8287866B2 (en) 2012-10-16
ATE547525T1 (de) 2012-03-15
ATE342980T1 (de) 2006-11-15
EP1337636A2 (fr) 2003-08-27

Similar Documents

Publication Publication Date Title
AU2001290524A1 (en) Soluble zcytor 11 cytokine receptors
WO1999037682A3 (fr) Anticorps contre il-12 humaine
CY1112787T1 (el) Πολλαπλομερη του υποδοχεα κυτοκινης ζcytor17
EP1749888A3 (fr) Récépteurs de cytokines zalpha11 solubles
DK0931092T3 (da) Varianter af vækstfaktor for vaskulære endotelceller med antagonistiske egenskaber
PT1066380E (pt) Receptor de celula t soluvel
CA2426679A1 (fr) Agents preventifs ou therapeutiques contre le psoriasis renfermant l'antagoniste de l'il-6 comme substance active
WO1999029729A3 (fr) Fonction et utilisation de l'antagoniste du recepteur de la neuropiline
EP2258725A3 (fr) Récepteur de la cytokine zcytor17
NO993866L (no) Legemiddel mot lymfatiske tumorer
WO1997010824A8 (fr) Utilisation d'antagonistes du recepteur 5ht1b pour le traitement de maladies vasculaires
WO2003089603A3 (fr) Recepteur de cytokine
KR980002066A (ko) 변이형 인간 성장호르몬 및 그의 용도
JP2004500325A5 (fr)
TR199901636T2 (xx) �mm�nolojik hastal�klar�n tedavisi i�in terap�tik maddeler olarak ��z�n�r lenfotoksin-beta resept�rleri, anti-lenfotoksin resept�r� antikorlar� ve anti-lenfotoksin ba�� antikorlar�.
ATE542138T1 (de) Her-2-bindungsantagonisten
ATE442387T1 (de) Dimerisierter t-zell rezeptor fragment, dessen zusammensetzungen und verwendung
WO2003011907A3 (fr) Recepteur, son utilisation, et anticorps de souris
WO2004033705A3 (fr) Antagonistes des interferons viraux et utilisations de ceux-ci
WO2002007676A3 (fr) Composés à affinité pour le récepteur du facteur de stimulation des colonies de granulocytes (g-csfr)
AR010333A1 (es) Una muteina ob, una secuencia de adn, un vector de expresion una celula hospedadora procariota o de mamifero, un baculovirus recombinante, una celulahospedadora, un metodo para la produccion de una muteina ob, una composicion farmaceutica, el uso de una proteina ob para la preparacion de una composi
IL154777A0 (en) Il-6 receptor/il-6 chimera in huntington's disease
WO2001023563A3 (fr) Compositions et methodes therapeutiques utilisant des proteines morphogeniques, des hormones et des recepteurs d'hormones
EP1736545A3 (fr) Récepteurs de cytokines zcytor 11 solubles
WO2002022658A3 (fr) Muteines du fragment peptidique cgrp 1-7 et leur utilisation comme amplificateurs des recepteurs nicotiniques neuronaux